US$ 24.53
pharma news today glp-1 obesity drugs today π Millions More Americans Gain Affordable Access to Weight-Loss Through Medicare Starting today, millions of eligible Medicare beneficiaries can access leading medications for as little as $50 per month under Weight loss with GLP-1 medicines
Description
Food and Drug Administration issued concerns over the use of unapproved versions of glucagon-like peptide-1 (GLP-1) receptor agonists used for weight loss

Sarah Fishman, M.D., a professor of medicine, endocrinology, diabetes, and bone disease at Icahn School of Medicine at Mount Sinai in New York City
However, theres another approach to this expanding issue

10.2337/dc13-2618
This personalized approach highlights the importance of managing GLP-1 interactions effectively
Mohamed, K